Plasma levels of NT-proBNP in OSAS patients before CPAP treatment. Relationship to ventricular dysfunction. Preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
NT-proBNP correlates with RVEF in patients suffering from pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006
proBNP is not elevated in patients with advanced COPD and normal left cardiac function Source: Eur Respir J 2007; 30: Suppl. 51, 707s Year: 2007
Relation of troponin and hert type fatty acid protein (H-FABP) levels to echocardiographic and cardiac infarction injury score (CIS) with patients with prespiratory insufficiency due to COPD attack Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
NT-proBNP variation in stable pulmonary arterial hypertension patients. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
Echocardiographic abnormalities in patients with COPD at their first hospital admission Source: Eur Respir J 2013; 41: 784-791 Year: 2013
Prognostic value of echocardiography, BNP and cardiac troponin I (cTnI) in normotensive patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005
Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Relationship between cardiac Troponin-T and Tei index of the right ventricular in patients with hemodynamical stable PE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Connection of traditional echocardiographic and tissue doppler imaging parameters and brain natriuretic peptide levels in patients with different forms of pulmonary hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005
Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006
Prevalence and severity of cardiac dysrhythmias correlate with echocardiographic findings in sleep apnoea/hypopnoea syndrome B Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004
Prognostic significance of right ventricular dysfunction detected by CT/Echocardiography and biomarkers in normotensive patients with pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Echocardiographic findings in male patients with OSA: before and after positive airway pressure Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
The relation of ventricular ectopic beats with pulmonary hypertension in patients with systemic sarcoidosis without clinical evidence of cardiac involvement Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004